194 related articles for article (PubMed ID: 36615181)
1. IgG and IgE Autoantibodies to IgE Receptors in Chronic Spontaneous Urticaria and Their Role in the Response to Omalizumab.
Maronese CA; Ferrucci SM; Moltrasio C; Lorini M; Carbonelli V; Asero R; Marzano AV; Cugno M
J Clin Med; 2023 Jan; 12(1):. PubMed ID: 36615181
[No Abstract] [Full Text] [Related]
2. Co-occurrence of IgE and IgG autoantibodies in patients with chronic spontaneous urticaria.
Asero R; Marzano AV; Ferrucci S; Lorini M; Carbonelli V; Cugno M
Clin Exp Immunol; 2020 Jun; 200(3):242-249. PubMed ID: 32115683
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune chronic spontaneous urticaria.
Kolkhir P; Muñoz M; Asero R; Ferrer M; Kocatürk E; Metz M; Xiang YK; Maurer M
J Allergy Clin Immunol; 2022 Jun; 149(6):1819-1831. PubMed ID: 35667749
[TBL] [Abstract][Full Text] [Related]
4. Anti-TPO IgG/Total IgE Ratio: Biomarker for Omalizumab Response Prediction in Chronic Spontaneous Urticaria.
Brás R; Esteves Caldeira L; Bernardino A; Costa C
Int Arch Allergy Immunol; 2023; 184(9):866-869. PubMed ID: 37557083
[TBL] [Abstract][Full Text] [Related]
5. Differentiation between control subjects and patients with chronic spontaneous urticaria based on the ability of anti-IgE autoantibodies (AAbs) to induce FcεRI crosslinking, as compared to anti-FcεRIα AAbs.
Izaki S; Toyoshima S; Endo T; Kanegae K; Nunomura S; Kashiwakura JI; Sasaki-Sakamoto T; Nakamura R; Akiyama H; Ra C; Hayama K; Terui T; Okayama Y
Allergol Int; 2019 Jul; 68(3):342-351. PubMed ID: 30803853
[TBL] [Abstract][Full Text] [Related]
6. The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria.
Chang TW; Chen C; Lin CJ; Metz M; Church MK; Maurer M
J Allergy Clin Immunol; 2015 Feb; 135(2):337-42. PubMed ID: 24948369
[TBL] [Abstract][Full Text] [Related]
7. Improved FcεRI-Mediated CD203c Basophil Responsiveness Reflects Rapid Responses to Omalizumab in Chronic Spontaneous Urticaria.
Oda Y; Fukunaga A; Washio K; Imamura S; Mizuno M; Hatakeyama M; Ogura K; Nishigori C
J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1166-1176.e8. PubMed ID: 32898709
[TBL] [Abstract][Full Text] [Related]
8. Most Patients With Autoimmune Chronic Spontaneous Urticaria Also Have Autoallergic Urticaria, but Not ViceVersa.
Xiang YK; Kolkhir P; Scheffel J; Sauer M; Vera C; Frischbutter S; Krause K; Siebenhaar F; Metz M; Maurer M; Altrichter S
J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2417-2425.e1. PubMed ID: 36805105
[TBL] [Abstract][Full Text] [Related]
9. Response of FcεRI-bearing leucocytes to omalizumab in chronic spontaneous urticaria.
Alizadeh Aghdam M; Knol EF; van den Elzen M; den Hartog Jager C; van Os-Medendorp H; Knulst AC; Otten HG; Röckmann H
Clin Exp Allergy; 2020 Mar; 50(3):364-371. PubMed ID: 31925825
[TBL] [Abstract][Full Text] [Related]
10. IL-24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria.
Schmetzer O; Lakin E; Topal FA; Preusse P; Freier D; Church MK; Maurer M
J Allergy Clin Immunol; 2018 Sep; 142(3):876-882. PubMed ID: 29208545
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin.
Metz M; Staubach P; Bauer A; Brehler R; Gericke J; Kangas M; Ashton-Chess J; Jarvis P; Georgiou P; Canvin J; Hillenbrand R; Erpenbeck VJ; Maurer M
Theranostics; 2017; 7(5):1266-1276. PubMed ID: 28435464
[No Abstract] [Full Text] [Related]
12. Biomarkers of Autoimmune Chronic Spontaneous Urticaria.
Larenas-Linnemann D
Curr Allergy Asthma Rep; 2023 Dec; 23(12):655-664. PubMed ID: 38064133
[TBL] [Abstract][Full Text] [Related]
13. Thyroid Autoimmunity in CSU: A Potential Marker of Omalizumab Response?
Asero R; Ferrucci SM; Calzari P; Consonni D; Cugno M
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108654
[TBL] [Abstract][Full Text] [Related]
14. Chronic spontaneous urticaria: new evidences on the role of autoimmunity.
Xiang YK; Guloglu S; Elieh-Ali-Komi D; Kocatürk E
Curr Opin Allergy Clin Immunol; 2023 Oct; 23(5):438-445. PubMed ID: 37459281
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study.
Schoepke N; Asero R; Ellrich A; Ferrer M; Gimenez-Arnau A; E H Grattan C; Jakob T; Konstantinou GN; Raap U; Skov PS; Staubach P; Kromminga A; Zhang K; Bindslev-Jensen C; Daschner A; Kinaciyan T; Knol EF; Makris M; Marrouche N; Schmid-Grendelmeier P; Sussman G; Toubi E; Church MK; Maurer M
Allergy; 2019 Dec; 74(12):2427-2436. PubMed ID: 31228881
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.
Kaplan AP; Giménez-Arnau AM; Saini SS
Allergy; 2017 Apr; 72(4):519-533. PubMed ID: 27861988
[TBL] [Abstract][Full Text] [Related]
17. BTK signaling-a crucial link in the pathophysiology of chronic spontaneous urticaria.
Bernstein JA; Maurer M; Saini SS
J Allergy Clin Immunol; 2024 May; 153(5):1229-1240. PubMed ID: 38141832
[TBL] [Abstract][Full Text] [Related]
18. Predicting the Speed of Response to Omalizumab in Chronic Spontaneous Urticaria.
Keskinkaya Z; Kaya Ö; Işık Mermutlu S; Öğretmen Z
Int Arch Allergy Immunol; 2024 Apr; ():1-8. PubMed ID: 38626739
[TBL] [Abstract][Full Text] [Related]
19. Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both.
Chen Y; Yu M; Huang X; Tu P; Shi P; Maurer M; Zhao Z
World Allergy Organ J; 2021 Jan; 14(1):100501. PubMed ID: 33510832
[TBL] [Abstract][Full Text] [Related]
20. Low Responsiveness of Basophils via FcεRI Reflects Disease Activity in Chronic Spontaneous Urticaria.
Oda Y; Fukunaga A; Washio K; Imamura S; Hatakeyama M; Ogura K; Nishigori C
J Allergy Clin Immunol Pract; 2019; 7(8):2835-2844.e7. PubMed ID: 31136822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
